Table 2

Cox proportional hazards model for association of FLC abnormalities with clinical outcome: unadjusted in all patients, adjusted for Rai stage in all patients, and unadjusted in patients with Rai stage 0

All patients, unadjusted
All patients, adjusted for Rai stage
Rai stage 0 only
HR95% CIPHR95% CIPHR95% CIP
TTFT          
    Normal FLC 1.00 Ref — 1.00 Ref — 1.00 Ref — 
    Monoclonal FLC elevation 5.57 3.29-9.44 < .001 4.23 2.47-7.25 < .001 7.49 1.77-31.6 .0062 
    Polyclonal FLC elevation 2.12 1.08-4.17 .029 1.52 1.06-4.12 .25 2.73 0.46-16.7 .27 
    Ratio-only FLC abnormality 2.75 1.51-5.03 .0010 2.19 1.20-4.02 .011 9.08 2.27-36.4 .0018 
OS          
    Normal FLC 1.00 Ref — 1.00 Ref — 1.00 Ref — 
    Monoclonal FLC elevation 5.38 2.23-12.98 .001 4.89 2.00-11.92 .001 10.50 2.49-44.26 .0014 
    Polyclonal FLC elevation 5.37 2.19-13.17 .001 4.76 1.90-11.89 .001 5.00 1.00-24.92 .050 
    Ratio-only FLC abnormality 0.38 0.05-3.03 .36 0.34 0.04-2.67 .30 NA   
All patients, unadjusted
All patients, adjusted for Rai stage
Rai stage 0 only
HR95% CIPHR95% CIPHR95% CIP
TTFT          
    Normal FLC 1.00 Ref — 1.00 Ref — 1.00 Ref — 
    Monoclonal FLC elevation 5.57 3.29-9.44 < .001 4.23 2.47-7.25 < .001 7.49 1.77-31.6 .0062 
    Polyclonal FLC elevation 2.12 1.08-4.17 .029 1.52 1.06-4.12 .25 2.73 0.46-16.7 .27 
    Ratio-only FLC abnormality 2.75 1.51-5.03 .0010 2.19 1.20-4.02 .011 9.08 2.27-36.4 .0018 
OS          
    Normal FLC 1.00 Ref — 1.00 Ref — 1.00 Ref — 
    Monoclonal FLC elevation 5.38 2.23-12.98 .001 4.89 2.00-11.92 .001 10.50 2.49-44.26 .0014 
    Polyclonal FLC elevation 5.37 2.19-13.17 .001 4.76 1.90-11.89 .001 5.00 1.00-24.92 .050 
    Ratio-only FLC abnormality 0.38 0.05-3.03 .36 0.34 0.04-2.67 .30 NA   

Ref indicates reference group; and NA, not applicable because of limited number of patients or events in the subgroup.

Close Modal

or Create an Account

Close Modal
Close Modal